(+)-15-epi Cloprostenol-10 mg

Catalog No.: C08-0338-062
Mfr. No.: 10006692-10
Mfr. Name: Cayman Chemical Company
Qty/UOM: 1
UOM: EA

Price: $1,539.26

List Price: $1,710.29

Cloprostenol is a synthetic PGF2&alpha analog and a potent FP receptor agonist. (+)-15-epi Cloprostenol is the 15(S), or 15&beta-hydroxy enantiomer of (+)-cloprostenol.

To proceed with your purchase, please call customer service at (732)447-1102.

Note: Hazmat items cannot be delivered to a residential address.

Enjoy exclusive benefits including discounted pricing on orders by contacting our Sales Executives to open an account. Contact Us

Description
Specifications

Cloprostenol is a synthetic PGF2α analog and a potent FP receptor agonist. (+)-15-epi Cloprostenol is the 15(S), or 15β-hydroxy enantiomer of (+)-cloprostenol. This epimer is less active by several orders of magnitude as an FP receptor ligand when compared to 15(R)-cloprostenol. However, the specific activity of this isomer has not been well studied.

Shipping Information:

Hazmat Fee: $65.00 + applicable shipping charges are added after the order is placed.

More Information: https://cenmed.com/shipping-returns

UPC:: 51181927
Condition:: New
Availability:: 3 Days
Weight:: 1.00 Ounces
HazmatClass:: Yes
WeightUOM:: LB
MPN:: 10006692-10
CAS:: 54276-22-1

Cenmed Satisfaction Guarantee

At Cenmed, your confidence and satisfaction are paramount. We guarantee the quality and reliability of our extensive range of clinical and laboratory supplies. If you're not completely satisfied with your purchase, we offer a straightforward return process and dedicated support to resolve your concerns promptly. Our commitment ensures that you can order with confidence, knowing that Cenmed is dedicated to superior service and customer satisfaction. Trust us to meet your needs with every order, backed by our promise of excellence. Learn more in Help & FAQs.

"Cenmed provides me access to the same products/services normally reserved for much larger labs than mine. I was presently surprised by their product offering."